Answers are grounded in this paper and cite their sources.
BACKGROUND: Endobronchial ultrasound (EBUS) and transoesophageal ultrasound with a bronchoscope (EUS-B) are key techniques for mediastinal staging in lung cancer. The 9th TNM classification underscores the prognostic importance of accurate station-specific nodal assessment. However, the optimal sampling strategy remains uncertain, particularly regarding needle reuse between N2 stations due to the risk of cross-contamination. METHODS: We conducted a prospective multicentre study including patients undergoing EBUS and/or EUS-B for diagnosis or staging of lung cancer or metastatic disease. A standardised transbronchial needle aspiration (TBNA) cleaning protocol was evaluated. The primary endpoint was the absence of malignant cells in post-cleaning needle rinse samples. RESULTS: Of 164 enrolled patients, 162 were included in the final analysis, comprising 270 sampled targets, with malignancy confirmed in 76.3%. The mean cleaning time was 148.8 ± 40.9 seconds per target, and the needle was visually assessed as clean in 89.3% of cases. Among malignant cases, post-cleaning needle rinse samples were negative for malignant cells in 92.2% and positive or suspicious in 7.8%. No clinical or procedural variables were associated with cleaning failure. Visual assessment of needle cleanliness did not correlate with cytological findings. No complications were observed. CONCLUSION: A standardised needle-cleaning protocol is safe and effective in reducing malignant cell contamination during EBUS and EUS-B. However, residual contamination persists in a minority of cases, indicating that needle reuse may carry a small risk of cross-contamination between targets. This approach may represent a pragmatic alternative to routine needle exchange in clinical practice.
No takes yet. Share an insight, caveat, or question.
Bugalho et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: